|
Web
Education
International Journal Of
INTRODUCTION: Regulatory challenges in global pharmaceutical market lead to the new drug, and generics development to a large extent.For the globalization at the international level regulatory challenges contribute a great extent. As there are too many similarities around the world in concern with drug safety and availability, differences and similarities in regulatory system and drug markets ......
International Journal of Drug Regulatory Affairs | SlideShare
International Journal of Drug Regulatory Affairs: IJDRA a broad-spectrum, open-access & peer-reviewed International Pharmaceutical Journal circulated electronically via the world wide web. It cover the subjects - Regulatory Affairs, Intellectual Property Rights and Pharmaceutical Development and intended to be of interest to a broad audience of pharmaceutical professionals. IJDRA now ideally ......
iSEEK - Web
International Journal of Drug Regulatory Affairs: (IJDRA) is Quarterly Open-access and peer-reviewed Journal circulated electronically and Print since 2013 to provide the quality information on the latest updates on Drug regulation. It is the first Journal for subject Drug Regulatory Affairs in India and it publishes Research articles, Review ........
Home - International Journal of Pharmaceutical Research ...
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES. About Us. The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS) is an open access, online quarterly publishing journal, & is a peer-reviewed multi-disciplinary pharmaceutical & scientific journal serves scientific information, studies, and scientific outcomes of various international ......
Regulatory Affairs : Pharmaceutical Guidelines
The Regulatory Affairs department is an important part of the organizational structure of pharmaceutical companies. Internally it liaises at the interphase of drug development, manufacturing, marketing and clinical research.Externally it is the key interface between the company and the regulatory authorities.
BA/BE Studies | List of High Impact Articles | PPts ...
Bioequivalence is defined as the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.
|
